KATE SUGDEN: Open Payments
NPI 1225894835 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 102 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $597 · 2025 $2,339
Food & beverage: $2,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $735 |
| Janssen Biotech, Inc. | 18 | $480 |
| Lilly USA, LLC | 8 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $157 |
| PFIZER INC. | 6 | $96 |
| Celltrion USA Inc. | 3 | $59 |
| Ardelyx, Inc. | 3 | $58 |
| Braintree Laboratories, Inc. | 3 | $54 |
| Madrigal Pharmaceuticals | 3 | $53 |
Products named: TREMFYA, RINVOQ, SKYRIZI, OMVOH, XIFAXAN, ENTYVIO, DUPIXENT, VEGZELMA.
Industry payments across KS — which companies pay providers there.
